Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04024748 · ClinicalTrials.gov registry record

Verification of Imaging System PCD-1000A

A clinical trial of Cancer Patients, sponsored by Canon Medical Systems, U.

Completed
Registry status
24
Enrollment target
1
Study location

NCT04024748: Completed study of Cancer Patients, sponsored by Canon Medical Systems, U.

NCT04024748 is a study of Cancer Patients that has completed, run by Canon Medical Systems, U. The registered enrollment target is 24 participants, below the 241-participant average among 8 other Cancer Patients trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04024748, a study of Cancer Patients, has completed, sponsored by Canon Medical Systems, U.

COMPLETED
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

Scope Verification of technologies included in the PCD-1000A PET/CT imaging chain. * Define and confirm all supported clinical protocols * Evaluate performance

Primary Outcome

PCD-1000A PET/CT system's performance will be evaluated for oncology PET imaging on cancer patients to verify that the system performs as expected. • Verify that all supported clinical protocols from PET acquisition, reconstruction, to presentation (filtering) perform as expected. Images acquired by PCD-1000A PET/CT will be compared with images acquired during a standard-of-care PET/CT scan by a commercially available PET/CT system just prior to imaging with the PCD-1000A PET/CT System. Image q

Conditions Studied

Interventions

  • DEVICE PET/CT imaging

Study Locations (1)

Nevada

  • Steinberg Diagnostic Medical Imaging Centers - Henderson

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-10-22
Est. Completion 2019-11-26
Canon Medical Systems, U

1 total trials

What the finished NCT04024748 record still lists

NCT04024748 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 241-participant average among 8 other Cancer Patients trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Cancer Patients appearing as the primary indexed condition, and to 1 intervention - of which PET/CT imaging is the first listed.

NCT04024748 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT04024748 about?

NCT04024748 is a clinical study titled "Verification of Imaging System PCD-1000A". Scope Verification of technologies included in the PCD-1000A PET/CT imaging chain. * Define and confirm all supported clinical protocols * Evaluate performance

What is the current status of trial NCT04024748?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2019-10-22. Estimated completion is 2019-11-26.

What conditions does trial NCT04024748 study?

This clinical trial studies the following conditions: Cancer Patients.

What interventions are being tested in trial NCT04024748?

The interventions under investigation include: PET/CT imaging (DEVICE).

Who is sponsoring clinical trial NCT04024748?

This trial is sponsored by Canon Medical Systems, U, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04024748 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Patients

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04024748's enrollment target sits among peer trials

24 9th of 8 the lowest of 8 other Cancer Patients trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer Patients trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04024748, the US trial registry maintained by the National Library of Medicine. NCT04024748 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.